American Century Companies
VRCA icon

American Century Companies’s Verrica Pharmaceuticals VRCA Stock Holding History

American Century Companies’s Portfolio VRCA Stock Details VRCA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-1,570
Closed -$115K – 2964
2023
Q4 		$115K Buy
1,570
+42
+3% +$1.73K ﹤0.01% 2798
2023
Q3 		$59.3K Buy
+1,528
New +$77.7K ﹤0.01% 2787

Other funds holding VRCA

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return

American Century Companies's VRCA Position: Q1 2024 in Review

American Century Companies sold out of Verrica Pharmaceuticals (VRCA) in Q1 2024, closing a stake of 1,570 shares — an estimated $115K sold.

American Century Companies first reported a position in VRCA in Q3 2023 and held it in 2 quarters. The position peaked at $115K in Q4 2023. 60 funds tracked by Wall St. Rank hold VRCA as of Q1 2024.

  • American Century Companies reported no remaining Verrica Pharmaceuticals position as of Q1 2024 after selling out during the quarter.
  • American Century Companies sold 1,570 Verrica Pharmaceuticals shares in Q1 2024, an estimated $115K.
  • American Century Companies first reported a position in Verrica Pharmaceuticals in Q3 2023 and held it in 2 quarters.
  • American Century Companies's Verrica Pharmaceuticals position peaked at $115K in Q4 2023.
  • 60 funds tracked by Wall St. Rank held Verrica Pharmaceuticals as of Q1 2024.

Based on American Century Companies's 13F filing for Q1 2024, filed 14 May 2024.